Cargando…

GATA3-Driven Th2 Responses Inhibit TGF-β1–Induced FOXP3 Expression and the Formation of Regulatory T Cells

Transcription factors act in concert to induce lineage commitment towards Th1, Th2, or T regulatory (T(reg)) cells, and their counter-regulatory mechanisms were shown to be critical for polarization between Th1 and Th2 phenotypes. FOXP3 is an essential transcription factor for natural, thymus-derive...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantel, Pierre-Yves, Kuipers, Harmjan, Boyman, Onur, Rhyner, Claudio, Ouaked, Nadia, Rückert, Beate, Karagiannidis, Christian, Lambrecht, Bart N, Hendriks, Rudolf W, Crameri, Reto, Akdis, Cezmi A, Blaser, Kurt, Schmidt-Weber, Carsten B
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222968/
https://www.ncbi.nlm.nih.gov/pubmed/18162042
http://dx.doi.org/10.1371/journal.pbio.0050329
Descripción
Sumario:Transcription factors act in concert to induce lineage commitment towards Th1, Th2, or T regulatory (T(reg)) cells, and their counter-regulatory mechanisms were shown to be critical for polarization between Th1 and Th2 phenotypes. FOXP3 is an essential transcription factor for natural, thymus-derived (nT(reg)) and inducible T(reg) (iT(reg)) commitment; however, the mechanisms regulating its expression are as yet unknown. We describe a mechanism controlling iT(reg) polarization, which is overruled by the Th2 differentiation pathway. We demonstrated that interleukin 4 (IL-4) present at the time of T cell priming inhibits FOXP3. This inhibitory mechanism was also confirmed in Th2 cells and in T cells of transgenic mice overexpressing GATA-3 in T cells, which are shown to be deficient in transforming growth factor (TGF)-β–mediated FOXP3 induction. This inhibition is mediated by direct binding of GATA3 to the FOXP3 promoter, which represses its transactivation process. Therefore, this study provides a new understanding of tolerance development, controlled by a type 2 immune response. IL-4 treatment in mice reduces iT(reg) cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy.